Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Clin Pharmacol Ther. 2020 Feb 3;107(4):886–902. doi: 10.1002/cpt.1745

Table 1.

Data collection statistics for IR models

Training data Testing data
Study types Positive (N1) Negative (N2) Positive (N3) Negative (N4)
DDI
In-vitro PK 150* 10,000 150* 800
Clinical PK
Clinical PD
DGI 1,700 1,700 1,729 8,300

IR: information retrieval, PK: pharmacokinetics, PD: pharmacodynamics, DGI: drug-gene interactions

*

The 150 abstracts were different for training and testing as well as each of the in-vitro PK, clinical PK, and clinical PD DDI studies

Among 800 negative abstracts, 500 were single-drug or nutrition-related abstracts and 300 were randomly selected abstracts